PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK. Electronic address: a.j.turner@leeds.ac.uk.\', \'School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK; I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, Saint Petersburg, Russia; Pavlov Institute of Physiology, Russian Academy of Sciences, Saint Petersburg, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0196-9781(22)00032-810.1016/j.peptides.2022.170766
?:hasPublicationType
?:journal
  • Peptides
is ?:pmid of
?:pmid
?:pmid
  • 35151768
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.001
?:rankingScore_hIndex
  • 106
is ?:relation_isRelatedTo_publication of
?:title
  • Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all